Scienture Holdings, Inc. (SCNX) Stock

Healthcare · Pharmaceutical Retailers · Member of Other US Stocks

Scienture Holdings, Inc. (SCNX) closed at USD 3.35 on 2026-10-14, a change of -86.5 % over the past year, with a market capitalization of USD 5.55M.

Scienture Holdings, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Scienture Holdings, Inc. key figures

Previous close

USD 3.35 (2026-10-14)

1-year change

-86.5 %

Market cap

USD 5.55M

Enterprise value

USD 8.05M

P/E ratio (trailing)

-0.06

P/E ratio (forward)

n/a

EPS (trailing)

-54.87

EPS (forward)

0.00

PEG ratio

n/a

Price to book

0.09

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.89

Employees

4

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Scienture Holdings, Inc.

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is headquartered in Commack, New York.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Scienture Holdings, Inc. and compare it with other stocks.